PSYCH Symposium: Atlantic Psychedelics - From Discovery to Delivery

PSYCH Symposium's Atlantic Psychedelic panel explored the complexities that psychedelic compounds bring to drug development and speak of their experience on both sides of the Atlantic (US, Canada and UK) and within the Commonwealth (Australia).
Featuring:
George McBride, Chief Commercial Officer, Clerkenwell Health.
Clare Knight, Senior Clinical Trials Manager, Clerkenwell Health.
Nicholas Kadysh, Founding CEO & President, PharmAla Biotech.
Peter Mollison, CEO & Co-Founder, Eramol.
Dr. Guy Higgins, Chief Scientific Officer, Transpharmation Ltd.